Exelixis Announces Webcasts of Upcoming Investor Conference Presentations

Exelixis Announces Webcasts of Upcoming Investor Conference Presentations

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Exelixis, Inc. (Nasdaq: EXEL  ) announced today that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will present at two investor conferences this month.

  • Bank of America Merrill Lynch 2013 Healthcare Conference: Exelixis’ presentation is scheduled for 11:00 a.m. EDT / 8:00 a.m. PDT on Tuesday, May 14, 2013, in Las Vegas.
  • UBS 2013 Global Healthcare Conference: Exelixis’ presentation is scheduled for 9:30 a.m. EDT / 6:30 a.m. PDT on Tuesday, May 21, 2013, in New York.

During each presentation, Dr. Morrissey will review the company’s development plans and priorities for cabozantinib in 2013. He will also discuss the company’s corporate strategy and financial outlook, and provide a general business update.

Each presentation will be webcast and may be access via the Event Calendar page under Investors & Media at www.exelixis.com.

About Exelixis

Exelixis, Inc. is a biotechnology company committed to developing small molecule therapies for the treatment of cancer. Exelixis is focusing its proprietary resources and development efforts exclusively on COMETRIQ™ (cabozantinib). Exelixis has also established a portfolio of other novel compounds that it believes have the potential to address serious unmet medical needs, many of which are being advanced by partners as part of collaborations. For more information, please visit the company's web site at www.exelixis.com.



Exelixis, Inc.
Charles Butler, 650-837-7277
Vice President, Investor Relations and Corporate Communications
cbutler@exelixis.com

KEYWORDS:   United States  North America  California  Nevada  New York

INDUSTRY KEYWORDS:

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2419021, ~/Articles/ArticleHandler.aspx, 9/2/2014 10:12:42 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...